Dry Needling Versus Percutaneous Electrical Nerve Stimulation On Pain, Range Of Motion And Quality Of Life In Myogenous Masticatory Pain –A Randomized Controlled Trial
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- KLE Academy of Higher Education and Research
- Enrollment
- 36
- Locations
- 1
- Primary Endpoint
- 1. Pain severity - Numerical pain rating scale – NPRS
Overview
Brief Summary
This study is a randomized controlled trial evaluating the effectiveness of dry needling, percutaneous electrical nerve stimulation, conventional therapy [ultrasound and Rocabado exercises] in adults aged 18 to 40 years with myogenous masticatory pain MMP. Thirty six participants will be randomly assigned to one of three groups DN plus conventional, PENS plus conventional, or conventional only, each receiving treatment on alternate days for two weeks. Assessments include pain using NPRS and pain pressure threshold, jaw function JFLS 20 and maximum mouth opening, and quality of life OHIP14, with results analyzed for statistical significance. The aim is to determine which intervention provides the greatest improvements in pain relief, jaw mobility, and quality of life, thus guiding future clinical management in MMP cases where comparative data is lacking.
Study Design
- Study Type
- Interventional
- Allocation
- Coin toss, Lottery, toss of dice, shuffling cards etc
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 40.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Subjects willing to participate.
- •Age group between 18 to 40 years of both genders Participants with MMP with limited mouth opening and stiffness according to the Diagnostic Criteria for Temporomandibular Disorders Muscle tenderness of any of the muscles of mastication.
Exclusion Criteria
- •All the red flags of dry needling.
- •Polyarthritis, OA and arthralgia.
- •Any coexisting Infections around face and neck, TMJ arthritis, occlusive disorders, fibromyalgia or any neurologic disorder such as trigeminal neuralgia.
- •Any systemic sickness or simultaneous condition that could affect the orofacial area and interfere with the study protocol.
- •Injuries, use of anticoagulants or medications for circulation issues, metal allergies, and individuals with cognitive or communicative impairments that can impede the gathering of essential data.
Outcomes
Primary Outcomes
1. Pain severity - Numerical pain rating scale – NPRS
Time Frame: baseline and end of two weeks
2. Pain pressure threshold (PPT) – Pressure algometer
Time Frame: baseline and end of two weeks
3. The jaw functional limitations scales (JFLS-20)
Time Frame: baseline and end of two weeks
4. Maximum Mouth opening – Vernier calliper
Time Frame: baseline and end of two weeks
5. Quality of life - Oral health impact profile (OHIP-14)
Time Frame: baseline and end of two weeks
Secondary Outcomes
No secondary outcomes reported
Investigators
Preshita Shah
KAHER Institute Of Physiotherapy